Clinical trials - Press Releases

Date	Title	Company
28-Jul-2020	Zsolt Lavotha has been appointed acting CEO of Swedish Biomimetics 3000® Ltd	Swedish Biomimetics 3000®
28-Jul-2020	Chiesi publishes its annual report: Group generates almost €2 billion turnover and obtains B Corp certification in 2019	Chiesi Group
28-Jul-2020	Update on Phase 2b clinical study of lead asset XF-73 in the prevention of post-surgical bacterial infections	Destiny Pharma plc
28-Jul-2020	Fund+ Leads EUR38 Million Series B Financing in Indigo Diabetes NV	Fund+
28-Jul-2020	Oculis Announces Successful End-of-Phase 2 Meeting with the FDA for OCS-01 in Two Ophthalmology Indications	Oculis
28-Jul-2020	CPI, the Cell and Gene Therapy Catapult and MicrofluidX announce development of technology to rapidly scale up cell and gene therapy manufacture	CPI
28-Jul-2020	European Commission grants marketing authorisation for world’s first subcutaneous formulation of infliximab, Remsima® SC, for an additional five indications including for use in inflammatory bowel disease and ankylosing spondylitis	Celltrion Healthcare
28-Jul-2020	Chi-Med and Lilly to Collaborate in Commercializing Elunate® in China	Chi-Med
28-Jul-2020	Chi-Med’s NDA for Savolitinib in Non-Small Cell Lung Cancer Granted Priority Review in China	Chi-Med
28-Jul-2020	Awarded Contract from Codagenix Inc. New York USA for COVID-19 Vaccine Trial	Open Orphan plc
28-Jul-2020	Coulter Partners secures Chief Executive Officer for Optimapharm	Optimapharm
28-Jul-2020	Polyphor strengthens financial flexibility with CHF 19.3 million equity-linked financing	Polyphor
23-Jul-2020	UV-Concepts Announces Exclusive Agreement with Hytech Ireland to Distribute UV-C Enclosure (UVE™) Across Ireland and the United Kingdom	UV-Concepts Inc
22-Jul-2020	Collaboration with University College Dublin further expands its continuous flow platform	Almac Group
22-Jul-2020	Nouscom highlights cutting-edge science that led to the design of NOUS-209, a potential off-the-shelf neoantigen cancer vaccine for tumors with Microsatellite Instability	Nouscom
22-Jul-2020	Israel Ministry of Health Expands Testing Coverage for Non-Small Cell Lung Cancer Patients	Thermo Fisher Scientific
22-Jul-2020	IRBM to collaborate with MSD to develop peptides against coronavirus	IRBM
22-Jul-2020	Biotech company raises £2.25m for new spinal treatments	Locate Bio
22-Jul-2020	UCLB and Apollo Therapeutics secure first out-licensing deal to Deerfield, a leading U.S. healthcare investment firm	UCL Business
22-Jul-2020	UNION therapeutics announces acquisition of PDE4i compound class from LEO Pharma with oral lead candidate (orismilast) in Phase 2	UNION therapeutics A/S